Market Overview
The Major Depressive Disorder (MDD) Treatment Market is poised for steady expansion, anticipated to rise from USD 11,515 million in 2024 to USD 14,139.78 million by 2032, reflecting a compound annual growth rate (CAGR) of 2.6%. This growth underscores the increasing global awareness of mental health and the rising incidence of depressive disorders driven by modern lifestyle stressors, genetic predisposition, and comorbid chronic illnesses. The market is supported by advancements